4.6 Review

The Age-Related Macular Degeneration (AMD)-Preventing Mechanism of Natural Products

Journal

PROCESSES
Volume 10, Issue 4, Pages -

Publisher

MDPI
DOI: 10.3390/pr10040678

Keywords

age-related macular degeneration (AMD); natural products; preventing mechanism; dry AMD

Ask authors/readers for more resources

Age-related macular degeneration (AMD) is a visual disorder that affects the elderly, and the number of cases may increase due to the aging population. Current therapies for AMD include device-based treatments, anti-inflammatory drugs, anti-vascular endothelial growth factor treatments, and natural product treatments. Although AMD is incurable, its symptoms can be suppressed. Some natural products have shown potential in preventing early AMD by inhibiting cell death and activating anti-apoptotic pathways.
Age-related macular degeneration (AMD) is related to central visual loss in elderly people and, based on the increment in the percentage of the aging population, the number of people suffering from AMD could increase. AMD is initiated by retinal pigment epithelium (RPE) cell death, finally leading to neovascularization in the macula lutea. AMD is an uncurable disease, but the symptom can be suppressed. The current therapy of AMD can be classified into four types: device-based treatment, anti-inflammatory drug treatment, anti-vascular endothelial growth factor treatment, and natural product treatment. All these therapies have adverse effects, however early AMD therapy used with products has several advantages, as it can prevent RPE cell apoptosis in safe doses. Cell death (apoptosis) is caused by various factors, such as oxidative stress, inflammation, carbonyl stress, and a deficiency in essential components for cells, and RPE cell death is related to oxidative stress, inflammation, and carbonyl stress. Some natural products have anti-oxidative effects, anti-inflammation effects, and/or anti-carbonylation effects. The AMD preventive mechanism of natural products varies, with some natural products activating one or more anti-apoptotic pathways, such as the Nrf2/HO-1 anti-oxidative pathway, the anti-inflammasome pathway, and the anti-carbonyl pathway. As AMD drug candidates from natural products effectively inhibit RPE cell death, they have the potential to be developed as drugs for preventing early (dry) AMD.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available